Literature DB >> 26467388

Underlying risk factors for prescribing errors in long-term aged care: a qualitative study.

Amina Tariq1, Andrew Georgiou1, Magdalena Raban1, Melissa Therese Baysari2, Johanna Westbrook1.   

Abstract

OBJECTIVES: To identify system-related risk factors perceived to contribute to prescribing errors in Australian long-term care settings, that is, residential aged care facilities (RACFs). DESIGN AND
SETTING: The study used qualitative methods to explore factors that contribute to unsafe prescribing in RACFs. Data were collected at three RACFs in metropolitan Sydney, Australia between May and November 2011. Participants included RACF managers, doctors, pharmacists and RACF staff actively involved in prescribing-related processes. Methods included non-participant observations (74 h), in-depth semistructured interviews (n=25) and artefact analysis. Detailed process activity models were developed for observed prescribing episodes supplemented by triangulated analysis using content analysis methods.
RESULTS: System-related factors perceived to increase the risk of prescribing errors in RACFs were classified into three overarching themes: communication systems, team coordination and staff management. Factors associated with communication systems included limited point-of-care access to information, inadequate handovers, information storage across different media (paper, electronic and memory), poor legibility of charts, information double handling, multiple faxing of medication charts and reliance on manual chart reviews. Team factors included lack of established lines of responsibility, inadequate team communication and limited participation of doctors in multidisciplinary initiatives like medication advisory committee meetings. Factors related to staff management and workload included doctors' time constraints and their accessibility, lack of trained RACF staff and high RACF staff turnover.
CONCLUSIONS: The study highlights several system-related factors including laborious methods for exchanging medication information, which often act together to contribute to prescribing errors. Multiple interventions (eg, technology systems, team communication protocols) are required to support the collaborative nature of RACF prescribing. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Entities:  

Keywords:  Communication; Medication safety; Nursing homes; Process mapping; Teamwork

Mesh:

Year:  2015        PMID: 26467388     DOI: 10.1136/bmjqs-2015-004589

Source DB:  PubMed          Journal:  BMJ Qual Saf        ISSN: 2044-5415            Impact factor:   7.035


  4 in total

1.  Unmet Needs for Transdermal Patch Management in Electronic Medication Administration Records: An Analysis of Data from 66 Aged Care Facilities.

Authors:  Magdalena Z Raban; Melissa T Baysari; Mikaela L Jorgensen; Amina Tariq; Andrew Georgiou; Johanna I Westbrook
Journal:  Appl Clin Inform       Date:  2020-12-09       Impact factor: 2.342

2.  Polypharmacy and potentially inappropriate medications: a cross-sectional analysis among 451 nursing homes in France.

Authors:  Marie Herr; Helene Grondin; Stéphane Sanchez; Didier Armaingaud; Caroline Blochet; Antoine Vial; Philippe Denormandie; Joël Ankri
Journal:  Eur J Clin Pharmacol       Date:  2017-01-16       Impact factor: 2.953

3.  Process mapping in healthcare: a systematic review.

Authors:  Grazia Antonacci; Laura Lennox; James Barlow; Liz Evans; Julie Reed
Journal:  BMC Health Serv Res       Date:  2021-04-14       Impact factor: 2.655

4.  Evaluation of an intervention to improve the safety of medication therapy via HIT-supported interprofessional cooperation in long-term care - a mixed method study.

Authors:  Maria Magdalena Schreier; Stefan Pitzer; Johanna Katharina Dellinger; Dagmar Schaffler-Schaden; Jürgen Osterbrink; Maria Flamm
Journal:  BMC Health Serv Res       Date:  2022-10-03       Impact factor: 2.908

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.